The Cancer Therapy Evaluation Program (CTEP) is responsible, within DCTD, for coordinating the largest, publicly funded oncology clinical trials organization in the world. CTEP has more than 900 active trials enrolling more than 20,000 study participants annually, nearly 250 grants and cooperative agreements, and about 100 investigational new drugs (INDs). CTEP's staff of almost 60 talented physicians, scientists, pharmacists, nurses, and regulatory specialists, assisted by multiple government contractors, work diligently to assure the safe, efficient, and ethical conduct of this complex research enterprise. CTEP-sponsored research spans Phase I through III trials of all cancer types and treatment modalities — chemotherapy, targeted agents, immunotherapy, radiation, and surgery.
To learn more about CTEP portfolio, please visit CTEP Active Agreements.